Opthea IPO: What Investors Should Know About The Genentech, Regeneron Challenger
October 15, 2020 at 22:15 PM EDT
Opthea, an Australian clinical-stage biotech company, is going public to help fund its Phase 3 trials and take on two large biotech companies.
